RecruitingNot Applicable

Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

United States80 participantsStarted 2024-11-20

Plain-language summary

The bridge-enhanced ACL repair (BEAR) implant is a collagen-based scaffold loaded with whole blood. It is designed to promote healing in the setting of intraarticular knee pathology. This study would compare clinical outcomes and synovial fluid cytokine profiles in patients who undergo isolated meniscal repair with or without the BEAR implant.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • History of meniscus injury indicated for isolated repair, without concomitant ligament reconstruction or repair, cartilage repair procedure, or osteotomy. Exclusion Criteria: * Patients who are undergoing meniscal repair for displaced bucket-handle meniscal tears * Patients with a history of blood-borne diseases including HIV, hepatitis B virus, hepatitis C virus, human T-lymphotropic virus, and syphilis

What they're measuring

Change in International Knee Documentation Committee (IKDC) Subjective Knee Form Score

Timeframe: Baseline, 1 Year Post-Procedure

Change in Lysholm Scale Score

Timeframe: Baseline, 1 Year Post-Procedure

Change in Visual Analogue Scale (VAS) Score

Timeframe: Baseline, 1 Year Post-Procedure

Incidence of Repair Failure

Timeframe: Up to 1 Year Post-Procedure

Trial details

NCT IDNCT06041763

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11

Contact for this trial

Emma Trasatti

856-885-3259 Emma.trasatti@nyulangone.org

View on ClinicalTrials.gov More Meniscus Tear trials